Aliasger K. Salem
Affiliations: | Biomedical Engineering | University of Iowa, Iowa City, IA |
Area:
Biomedical Engineering, GeneticsGoogle:
"Aliasger Salem"Children
Sign in to add traineeJanjira Intra | grad student | 2008 | University of Iowa |
Treniece L. Terry | grad student | 2008 | University of Iowa |
Aiman O. Abbas | grad student | 2010 | University of Iowa |
Dahai Jiang | grad student | 2011 | University of Iowa |
Yogita Krishnamachari | grad student | 2011 | University of Iowa |
Vijaya B. Joshi | grad student | 2014 | University of Iowa |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Terry TL, Givens BE, Adamcakova-Dodd A, et al. (2021) Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo. Aaps Pharmscitech. 22: 69 |
Gross BP, Chitphet K, Wongrakpanich A, et al. (2020) Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine. Bioconjugate Chemistry |
Wilson-Welder JH, Boggiatto P, Nally JE, et al. (2020) Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms. Vaccine |
Wafa EI, Wilson-Welder JH, Hornsby RL, et al. (2020) Poly(diaminosulfide) Microparticle-Based Vaccine for Delivery of Leptospiral Antigens. Biomacromolecules |
Vishwakarma A, Bocherding N, Chimenti M, et al. (2020) Abstract A80: Mapping immune landscape in clear cell renal carcinoma by single-cell genomics Cancer Immunology Research. 8 |
Cheng Y, Lemke-Miltner CD, Chan CH, et al. (2020) Abstract 6641: In situ immunization with the TLR9-agonist CMP-001 enhances anti-PD1 therapy in head and neck tumors Immunology. 80: 6641-6641 |
Wafa EI, Geary SM, Ross KA, et al. (2019) Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine. Nanomedicine : Nanotechnology, Biology, and Medicine. 102055 |
Do AV, Smith R, Tobias P, et al. (2019) Sustained Release of Hydrogen Sulfide (HS) from Poly(Lactic Acid) Functionalized 4-Hydroxythiobenzamide Microparticles to Protect Against Oxidative Damage. Annals of Biomedical Engineering |
Terry TL, Givens BE, Rodgers VGJ, et al. (2019) Tunable Properties of Poly-DL-Lactide-Monomethoxypolyethylene Glycol Porous Microparticles for Sustained Release of Polyethylenimine-DNA Polyplexes. Aaps Pharmscitech. 20: 23 |
Vishwakarma A, Sun Y, Fu A, et al. (2019) Abstract B065: TANK-Binding Kinase 1 (TBK1) as a novel cancer immunotherapy target Molecular Cancer Therapeutics. 18 |